Page 829 - Cardiac Nursing
P. 829

LWBK340-c35_p799-822.qxd  29/06/2009  08:59 PM  Page 805 Aptara






                                                                                     C HAPTER  35 / Hypertension   805

                                                                       coat effect and is defined as the difference between the office
                   Table 35-3 ■ TRENDS IN AWARENESS, TREATMENT, AND    and daytime ambulatory BP; it is present in the majority of hy-
                   CONTROL AMONG PARTICIPANTS WITH HYPERTENSION        pertensive patients. Its magnitude can be reduced (but not
                   IN THE U.S. POPULATION, 1999 TO 2004                eliminated) by the use of stationary oscillometric devices that
                                                                       automatically determine and analyze a series of BPs over 15 to
                                National Health and Nutrition Examination
                                            Survey (%)                 20 minutes with the patient in a quiet environment in the of-
                                                                       fice or clinic.
                               1999–2000     2001–2002    2003–2004
                                                                         Masked HTN or Isolated Ambulatory HTN. The con-
                   Awareness      69            71           76        verse condition of normal BP in the office and elevated BPs else-
                   Treatment      58            60           65        where, such as at work or at home is somewhat less frequent than
                   Control †      29            33           37        white coat HTN but more problematic to detect. 66  Lifestyle can
                                                                       contribute to this, for example, alcohol, tobacco, and caffeine
                   † Among all with hypertension                       consumption and physical activity away from the clinic or office.
                   From Ong, K. L., Cheung, B., Man, Y. B., et al. (2007). Prevalence, awareness, treat-
                    ment, and control of hypertension among United States adults 1999–2004. Hyperten-
                        9
                        9
                    sion, 49, 69–75.                                   Clinical Evaluation
                                                                       The objectives of the medical assessment for HTN are to deter-
                                                                       mine (1) diagnosis and stage of HTN, (2) secondary causes of
                                                                       HTN, (3) presence of TOD, (4) level of global CVD risk, and (5)
                                                                       the plan for individualized monitoring and therapy. The assess-
                   to morbid events is the average level, although there is also ac-  ment should include a thorough history and physical examination,
                   cumulating evidence that suggests that hypertensive patients  including orthostatic BP change. Display 35-3 lists many of the
                   whose BP remains high at night (nondippers) are at greater risk  important variables to assess during the history and physical exam-
                   for cardiovascular morbidity than dippers. 67  Less data are avail-  ination. It is also important to ask the patient about any nontra-
                                                                            69
                   able to define the clinical significance of BP variability, although  ditional remedies they may be using including herbs, vitamins, and
                   it has been suggested that it is a risk factor for cardiovascular  other supplements. Display 35-4 lists the basic and optional labo-
                   morbidity.                                          ratory tests recommended by the Joint National Committee on
                     The recognition of these limitations of the traditional clinic  Prevention, Detection and Treatment of Hypertension (JNC 7) for
                   readings has led to two parallel developments: first, increasing use  the assessment of TOD.
                   of measurements made out of the clinic, which avoids the unrep-  Secondary HTN, a potentially curable condition, occurs in an
                   resentative nature of the clinic setting and also allows for increased  estimated 5% to 10% of HTN cases; therefore, clinicians should
                   numbers of readings to be taken; and second, the increased use of  evaluate for secondary causes (see Display 35-1). Additional eval-
                                                                                                         35
                   automated devices, which are being used both in and out of the  uation is recommended in patients whose age, severity of HTN,
                   office setting. 66,68  It is increasingly recognized that office meas-  medical history, physical examination, or laboratory findings are
                   urements correlate poorly with BP measured in other settings and  suggestive of secondary HTN. Poor response to antihypertensive
                   that they can be supplemented by self-measured readings taken  drug therapy or an accelerated phase of previously well-controlled
                   with validated devices at home. There is increasing evidence that  HTN also indicates a need for further investigation. 7
                   home readings predict cardiovascular events and are particularly
                   useful for monitoring the effects of treatment.
                                                                       Prognosis
                     Home BP Monitoring. Home BP monitoring overcomes
                   many of the limitations of traditional office BP measurement and  In the vast majority of cases, HTN cannot be cured. The rela-
                   is both cheaper and easier to perform than ambulatory BP moni-  tionship between BP and risk of CVD events is continuous, con-
                                                                                                          7
                   toring. Monitors using the oscillometric method are currently  sistent, and independent of other risk factors. For individuals
                   available and are accurate, reliable, easy to use, and relatively in-  aged 40 to 70 years, each increment of 20 mm Hg in SBP or
                   expensive. An increasing number of individuals are using them  10 mm Hg in DBP doubles the risk of CVD across the entire BP
                                                                                                      5
                   regularly to check their BP at home. Home BP monitoring has  range from 115/75 to 185/115 mm Hg. The effectiveness of
                   been endorsed by national and international guidelines and the  lifestyle and pharmacologic treatment in reducing BP has been
                   American Heart Association recently provided detailed recom-  demonstrated and substantial evidence indicates that controlling
                   mendations for their use. 68  Home BP monitoring has the poten-  BP in hypertensive patients significantly lowers risk of CV mor-
                                                                                       5,70–72
                   tial to improve the quality of care while reducing costs.  bidity and mortality.  A small reduction in BP could
                                                                       markedly reduce the risk of heart failure, stroke, and myocardial
                     White Coat HTN. Approximately 15% to 20% of people  infarction. 7,73  The recent improvements in HTN control rates
                   with stage 1 HTN have persistently elevated BP in the presence  and decreased mean BPs, especially among the older adults, may
                   of a health care worker, particularly a physician. However, when  help to decrease the incidence of strokes and heart attacks, which
                   BP is measured elsewhere, including at work, BP is not elevated.  is highly encouraging. 3
                   When this phenomenon is detected in patients not taking med-
                   ications, it is referred to as white coat HTN. The commonly  Prevention
                   used definition is a persistently elevated average office BP of
                    140/90 mm Hg and an average awake ambulatory reading of  The prevention of HTN is a major public health challenge. Many
                    135/85 mm Hg. 66  Although it can occur at any age, it is more  cases of HTN, cardiovascular and renal disease, and stroke might
                   common in older men and women. The phenomenon responsi-  be prevented if the rise in BP with age could be prevented or di-
                                                                              7
                   ble for white coat HTN is commonly referred to as the white  minished. The six interventions that have been shown to delay or
   824   825   826   827   828   829   830   831   832   833   834